Recommended Starting Dose of Pristiq for Anxiety
The recommended starting dose of Pristiq (desvenlafaxine) for anxiety is 50 mg once daily, which is both the initial and therapeutic dose. 1
Dosing Guidelines
Pristiq should be administered according to the following protocol:
- Start with 50 mg once daily
- Take with or without food
- Administer at approximately the same time each day
- Swallow tablets whole with fluid; do not divide, crush, chew, or dissolve
Key Considerations
- Clinical studies have evaluated doses ranging from 10 mg to 400 mg per day, but no additional benefit was demonstrated at doses greater than 50 mg daily 1
- Higher doses are associated with increased adverse reactions and discontinuations 1
- The 50 mg dose has shown efficacy in treating anxiety symptoms in patients with depression 2
Special Populations
Renal Impairment
- Moderate impairment (CrCl 30-50 mL/min): Maximum 50 mg/day
- Severe impairment (CrCl 15-29 mL/min): Maximum 25 mg/day or 50 mg every other day
- ESRD (CrCl <15 mL/min): Maximum 25 mg/day or 50 mg every other day
- Do not give supplemental doses after dialysis 1
Hepatic Impairment
- Moderate to severe impairment (Child-Pugh score 7-15): 50 mg/day
- Dose escalation above 100 mg/day not recommended 1
Efficacy in Anxiety
Desvenlafaxine 50 mg/day has demonstrated significant efficacy in treating anxiety symptoms:
- In a pooled analysis of seven randomized, placebo-controlled studies, desvenlafaxine 50 mg/day significantly improved depressive symptoms compared with placebo in patients with clinically relevant anxiety symptoms 2
- Response and remission rates were significantly higher with desvenlafaxine compared with placebo in patients with anxiety 2
Side Effects and Monitoring
Common adverse effects include:
- Insomnia
- Somnolence
- Dizziness
- Nausea 3
Switching and Discontinuation
When Switching to Pristiq
- Discontinuation symptoms may occur when switching from other antidepressants
- Taper the initial antidepressant to minimize discontinuation symptoms 1
When Discontinuing Pristiq
- Gradually reduce the dosage rather than stopping abruptly
- The 25 mg/day dose is intended for gradual reduction when discontinuing treatment 1
- Allow at least 7 days after stopping desvenlafaxine before starting an MAOI 1
Clinical Pearls
- Desvenlafaxine is the active metabolite of venlafaxine and has a similar efficacy profile 3
- Desvenlafaxine has decreased CYP2D6 activity compared to venlafaxine, which may be advantageous in patients taking other medications metabolized via this enzymatic pathway 3
- Treatment response is typically seen within 6-7 weeks at the standard dose 4
Remember that while this medication is effective for anxiety, treatment should be periodically reassessed to determine the need for continued therapy 1.